Q&A: Dr. Sheldon Holder, KCA Trailblazer Award winner

Dr. Sheldon Holder received a 2022 KCA Trailblazer Award for his research on the “Exploration of the causes and effects of increased PIM1 kinase activity in renal cell carcinoma”. Dr. Holder is a physician-scientist at … Continue reading Q&A: Dr. Sheldon Holder, KCA Trailblazer Award winner